• 검색 결과가 없습니다.

Absence of association between pretransplant serum soluble PD-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma

N/A
N/A
Protected

Academic year: 2021

Share "Absence of association between pretransplant serum soluble PD-1 level and prognosis following living donor liver transplantation in patients with hepatocellular carcinoma"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

AHBPSAnnals of Hepato-Biliary-Pancreatic Surgery

www.ahbps.org S119

Absence of association between pretransplant serum soluble PD-1 level and prognosis following

living donor liver transplantation in patients with hepatocellular carcinoma

Shin HWANG*

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

KAHBPS-1

Background: Programmed death protein 1 (PD-1) pathway is one of the most critical mechanisms in tumor biology of hepatocellular carcinoma (HCC). The study aimed to assess the prognostic influence of pretransplant serum soluble PD-1 (sPD-1) in patients under- going liver transplantation for treatment of HCC.

Methods: Data from 229 patients with HCC who underwent living donor liver transplantation between January 2010 and December 2015 were retrospectively evaluated. Stored serum samples were used to measure sPD-1 concentrations.

Results: Overall survival (OS) and disease-free survival (DFS) rates were 94.3% and 74.5% at 1 year; 78.2% and 59.2% at 3 years; and 75.4% and 55.5% at 5 years, respectively. Prognostic analysis using pretransplant serum sPD-1 with a cutoff of 93.6 µg/mL (median value of the study cohort) did not have significant prognostic influence on OS (p = 0.69) and DFS (p = 0.26). Prognostic analysis using sPD-1 with a cutoff of 300 µg/mL showed similar OS (p = 0.46) and marginally lower DFS (p = 0.070). Combination of Milan criteria and sPD-1 with a cutoff of 300 µg/mL showed similar outcomes of OS and DFS in patients within and beyond Milan criteria. Multi- variate analysis revealed that only Milan criteria was an independent prognostic for OS and DFS, but pretransplant sPD1 with a cutoff of 300 µg/mL did not become a prognostic factor.

Conclusions: The results of this study demonstrate that pretransplant serum sPD-1 did not show significant influences on post-trans- plant outcomes in patients with HCC. Further large-scale, multicenter studies are necessary to clarify the role of serum sPD-1 in liver transplantation recipients.

pISSN: 2508-5778ㆍeISSN: 2508-5859

Ann Hepatobiliary Pancreat Surg 2021;25 Suppl 1:S119 https://doi.org/10.14701/ahbps.KAHBPS-1

Corresponding Author: Shin HWANG ([email protected]) Presenter: Shin HWANG ([email protected])

Copyright Ⓒ The Korean Association of Hepato-Biliary-Pancreatic Surgery

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

참조

관련 문서

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.. McPherson S, Hardy T, Henderson

In the analysis of soluble solids, the treatment group with material grains and the combined groups of glutinous millet and barley appeared high, and

Objective: The purpose of this study was to analyze recent trend in incidence of basal cell carcinoma and squamous cell carcinoma in patients from the Gwangju City

The purpose of this study was to identify the frequency and related factors of advanced airway management for patients with cardiac arrest by the

Figure.11 1 1 1.The cell growth, soluble glucan producti .The cell growth, soluble glucan producti .The cell growth, soluble glucan producti .The cell growth, soluble glucan

We included patients who met the following criteria: 1) base- line serum uric acid level was measured within 7 days before the initiation of edaravone treatment; 2) follow-up

In the subgroup of patients who reached ASDAS-ID 1 year after TNFi treatment ( n = 327), ASDAS-ID was observed in 66.1% of the subsequent intervals, and only the

Thus, in the present study, we aimed to compare protein pro- files between achalasia patients and healthy controls using the serum proteomic analysis for the detection of